Page 2 - Pharmaceuticals

Gilead's antiviral drug remedesivir being made in India on trial basis

Local drug makers start developing patented drug as govt too wishes to try it on Indians

Investors should stick to stocks of firms focused on domestic market

Pharma firms can build brands and enjoy higher margins here

Four fallouts of Covid-19 mishandling

A disruption in supply chain, no cash flow, non-availability of labour, and the fall in purchasing power will break many businesses

Bharat Biotech joins global efforts in developing coronavirus vaccine

CoroFlu will build on the backbone of vaccine firm FluGen's flu vaccine candidate, a self-limiting version of the influenza virus that induces an immune response against the flu.

India may soon ease some drug export curbs under US pressure: Report

Imports from India accounted for 24% of medicines and 31% of medicine ingredients to the United States in 2018, according to the US Food and Drug Administration

Coronavirus shutdown puts Rs 15-trillion debt at risk, to impact finances

These 201 indebted firms paid Rs 1.1 trillion as interest in April-December 2019

Coronavirus lockdown hits medicine supply, chemists' body seeks govt help

The chemists' association reached out to the (DoP), state chief ministers and even to the Prime Minister's Office highlighting the challenges faced in transporting medicines

Crude to snuff gains from weak rupee, muted global demand to hurt exports

Tourism and hospitality, auto and aviation could see a demand crunch amid coronavirus; earnings from rupee depreciation to export-driven sectors such as IT and pharma could be limited

Choke in API supplies from China creates huge opportunity for Divi's Labs

Niche capabilities and absence of regulatory overhangs are other key positives

Rs 22,000 cr investments made in Andhra Pradesh since June 2019: State govt

Though oil giant Saudi Aramco was supposed to be a largest investor, particularly in the PCPIR in Visakhapatnam, it went away to Maharashtra

Govt asks pharma groups to ensure companies follow ethical practices

The DoP drafted the UCPMP has been voluntarily followed by drug firms since 2015., however, the code is not mandatory

US health regulator sends stern letter to GPT Pharma about Hyderabad plant

The company has 15 working days to explain to the Food and Drug Administration how it has improved manufacturing standards.

Novo Nordisk appoints Vikrant Shrotriya as MD, Corp V-P for India business

He returns to India after 13 years with an overall career spanning over 20 years in the healthcare industry in India and internationally

Sanofi to sell surgical product unit Seprafilm to Baxter for $350 mn

The deal should close by the end of the first quarter of 2010, Baxter added in a statement confirming the purchase, which was reported earlier by Reuters

Crocin 2.0: GSK is reinventing the pain-reliever brand to keep it relevant

The British multinational adds a fresh extension to its 40-year-old flagship, hopes to leverage the brand's recall to expand its remedial reach

Post-monsoon Indian pharma market growth slips to 5.1% in October

The drop in growth for the month of October 2019 has been seen across the therapies.

Govt plans to set up hubs for manufacturing medical devices, bulk drugs

Eight proposed parks aim to reduce import dependence, boost local manufacturing

Strides Pharma likely to launch affordable insulin from Stelis stable

The Bengaluru-headquartered company believes Stelis could be a disruptor in insulin accessibility and affordability.

Seven of top 10 drug brands sold in India are from multinational companies

The top 10 corporates contribute to 43% of the domestic pharma market

Divi's Labs cash in on bullish sentiment, strong growth prospects

The second largest pharma player by market value is also expanding capacities to push earnings